In March there was an abundance of funding raised by companies in the Biotech and Biopharma space. Within this blog, Invenia Group Consultant Katie Davis dives into key findings, and the companies raising these funds. You can subscribe to monthly biotech funding updates over on LinkedIn to keep up to date with the ever-growing biotech market.
Acquisitions, spin-outs and expansions
NeoGenomics Laboratories has acquired Pathline, a certified lab in New Jersey, to expand its footprint in the Northeast. The move strengthens its capabilities in molecular and hematology-oncology testing and supports growth in a key, fast-growing region.
Repligen Corporation, a life sciences company focused on bioprocessing technology, has purchased 908 Devices’ desktop portfolio of four devices for bioprocessing process analytical technology applications. 908 Devices remains focused on the growth of its newly expanded handheld device portfolio for vital health and safety applications.
InformedDNA has acquired Coriell Life Sciences to expand its precision health offerings. This move combines pharmacogenomic services with InformedDNA’s genetic test interpretation and counseling, enhancing access to personalized, data-driven care for patients, providers, and payors.
Advanced Instruments, LLC, a Patricia Industries subsidiary, has signed a definitive agreement to acquire Nova Biomedical. The acquisition brings together two leading manufacturers of analytical instruments, enhancing capabilities in both biopharmaceutical development and clinical diagnostics.
Momentum Biotechnologies, a CRO specializing in mass spectrometry-based drug discovery, announced that it has successfully completed the acquisition of OmicScouts, a Munich-based CRO and established leader in the field of mass spectrometry-based proteomics, operating hereafter as OmicScouts , a Momentum Biotechnologies Company.
Angsana Molecular & Diagnostic Laboratory Pte Ltd and Pathnova Laboratories have merged to create Archerfish Precision Diagnostics, combining strengths in molecular diagnostics, serology, and AI. The new entity aims to become a leading provider of advanced clinical diagnostic solutions in Singapore.
AccuStem announced that it has acquired the license for the proprietary MicroRNA Signature Classifier (MSC) test for lung cancer screening from three Italian researchers at the Fondazione IRCCS Istituto Nazionale dei Tumori di Milano
PerkinElmer has acquired Project Farma (PF), a subsidiary of Precision for Medicine, to expand its capabilities in life sciences consulting. Project Farma specializes in supporting technical operations from concept to commercialization, including project management, validation, and quality compliance.
Labcorp has announced an agreement to acquire select assets from OPKO Health’s BioReference, specifically its U.S.-based oncology and oncology-related clinical testing businesses. The move will enhance Labcorp’s cancer diagnostics portfolio and expand patient and provider access to its testing services.
Pow.Bio unveils state-of-the-art facility in Alameda, expanding biomanufacturing capabilities to support demand for continuous fermentation.
Nikon Microscope Solutions announced the opening of the newest Nikon Center of Excellence at the Moffitt Cancer Center. This prestigious designation underscores Nikon’s commitment to providing cutting-edge imaging technology directly to healthcare facilities such as Moffitt Cancer Center for the purpose of developing better cancer treatments and cures.
KAMADA announces expansion of plasma collection operations with the opening of new site in San Antonio, Texas
SHIMADZU CORPORATION and DxD Hub – Diagnostics Development Hub are collaborating to establish the Shimadzu-DxD Hub Diagnomics Centre (SDDC). The center, based at Singapore’s Biopolis, aims to accelerate the development of high-quality, cost-effective diagnostic products by integrating expertise from Shimadzu with product development platforms from DxD Hub. It will focus on infectious diseases, cancer, and metabolic disorders.
Legal updates
Parse Biosciences has agreed to a worldwide permanent injunction, admitting infringement of 10x Genomics’ ATAC-seq patents and halting the sale of its planned ATAC and ATAC-Multiome Single Cell products.
The US District Court for the Eastern District of Texas ruled to vacate the US FDA’s final rule on laboratory-developed tests (LDTs). The ruling prevents the FDA rule on LDTs, which is opposed by much of the clinical laboratory industry and many segments of the broader healthcare industry, from going into effect.
Judge denies QIAGEN ‘s motion to dismiss an antitrust lawsuit filed by Zymo Research Corp.
Promega Corporation this week filed a patent infringement lawsuit against Aobious Inc in the US District Court for the District of Delaware. The suit concerns IP rights around the enzyme furimazine and its associated variants, which the company uses in its NanoLuc luciferase technology.
The Chinese Ministry of Commerce banned Illumina from importing its next-generation sequencers into China, effective immediately.
Collaborations and partnerships
BioTuring has announced 2 partnerships:
- With Complete Genomics to streamline spatial data analysis! This collaboration integrates BioTuring’s SpatialX platform, compatible with STOmics spatial transcriptomics, to simplify complex data analysis and empower researchers to uncover vital biological insights.
- With Vizgen, by integrating Vizgen’s MERSCOPE Ultra™ platform with BioTuring’s SpatialX deep learning platform for analyzing data, researchers gain streamlined access to deeper insights into cellular interactions and complex tissue architecture.
Complete Genomics entered separate partnerships with the Human Cell Atlas (HCA) consortium and bioinformatics firm BioTuring to enhance the company’s spatial biology offerings to customers.
Vizgen have announced multiple partnerships:
- With Scale Biosciences to help researchers unlock deeper biological insights through the complementary technologies from Vizgen’s MERSCOPE® Platform and Scale Bio’s single-cell RNA and DNA methylation sequencing.
- They welcomed long-time collaborators at the Sanderson Center for Optical Experimentation (SCOPE) to their global Certified Service Provider network
- They became a commercial discount partner with the Human Cell Atlas (HCA)
- They partnered with Boudicca DX, a global precision medicine consulting firm to support Vizgen in advancing its clinical, regulatory and technical strategies for its spatial biology and multiomics tissue-based assays.
DNAnexus announced collaboration with Alida Biosciences to enhance RNA modification and expression analysis.
Alamar Biosciences, Inc. announced the signing of five new distribution partners to expand its global presence. The newly signed distribution partners include GeneWorks (Australia and New Zealand), Genomax Technologies (Singapore), PhileKorea (South Korea), Scrum Inc. (Japan) and Spinco Biotech (India)
STOmics announced Cancer Discovery Hub as a new Certified Service Provider (CSP). This partnership promises to bring state-of-the-art spatial transcriptomics technology, Stereo-seq, to a broader range of research communities.
Nomic Bio entered into an agreement with Novo Nordiskto integrate their nELISA™ proteomics platform within Novo’s multi-omics target discovery engine.
Psomagen and Aspect Analytics have entered into a partnership to provide state-of-the-art bioinformatics services to mutual customers, particularly for spatial multiomic data.
SeqOne partnered with LongSeq Applications in Spain, bringing together the power of long-read sequencing and advanced variant analysis! With this collaboration, LongSeq customers in Spain can easily integrate their Oxford Nanopore sequencing data into SeqOne’s AI-powered platform for faster variant analysis.
Aiforia Technologies announced multiple collaborations including:
- Extending their collaboration with Orion Pharma to include the use of Aiforia’s software solution for preclinical study evaluations.
- Extending their collaboration with USCAP – United States and Canadian Academy of Pathology to support eLearning for pathologists
- With PathPresenter to broaden the reach and adoption of Aiforia’s AI-powered image analysis solutions by utilizing PathPresenter’s comprehensive pathology workflow platform
- With Techcyte to accelerate the adoption of AI-driven workflows in anatomic pathology laboratories worldwide.
- With Quorum Technologies to accelerate the adoption of Aiforia’s AI-assisted image analysis solutions across Canada.
- The regional health authority of Sardinia in Italy has selected Aiforia Technologies as a partner for AI-assisted diagnostics.
Thermo Fisher Scientific announced a Technology Alliance Agreement with the Chan Zuckerberg Institute for Advanced Biological Imaging (CZ Imaging Institute). This agreement aims to develop new technologies to enable researchers to better visualize human cells, significantly advancing scientific research and discovery.
Genome Canada has launched the Canadian Precision Health Initiative (CPHI) which aims to collect and analyze 100,000 genomes from Canada’s diverse population. With a total expected investment of C$200 million, the initiative involves partners across industry, academia, and government. Regional genome centers and sequencing facilities will lead efforts, with sequencing support from Illumina, Oxford Nanopore Technologies and PacBio. CPHI aims to advance precision health, support cancer research, and ensure ethical genomic data use.
Lumea , AIRA Matrix Private Limited, and Acupath Laboratories Inc. have partnered to deliver an AI-based solution to assist in the diagnosis of urinary bladder cancers through cytopathological examination.
Integrated DNA Technologies signed an agreement with ELEGEN to offer that company’s Enfinia Plasmid DNA synthesis service for long and high-complexity clonal genes before its official release.
Dovetail Genomics announce the inclusion of the Centro Nacional de Análisis Genómico (CNAG) as the newest member of the Dovetail® Certified Service Provider (CSP) program
Quantum-Si welcomed Medsol Corporation as their official distributor in the middle east covering Egypt, Morocco, Algeria and Jordan.
Twist Bioscience and CURIO Genomics announced a collaboration to accelerate the adoption of NGS workflows in agricultural genomics (agrigenomics).
Labor Dr. Wisplinghoff has partnered with Genomic Testing Cooperative to offer advanced NGS DNA/RNA testing in Germany. This collaboration enhances diagnostic and therapy monitoring capabilities for solid tumours and hematologic cancers, with a strong focus on RNA analysis to support precision medicine.
Parse Biosciences welcomed the South Australian Genomics Centre (SAGC)to its Certified Service Provider Program.
Belay Diagnostics partners with GenomOncologyto support high-performance liquid biopsy test for CNS cancer detection.
GenomOncology has partnered with Chronetyx Laboratories to reduce the turnaround time for sequencing-based cancer testing.
Kiffik Biomedical, Inc. and Rubix LS partner to revolutionize cancer diagnostics with interstitial fluid and aptamer technologies
Leveragen announced a comprehensive collaboration with Cell Signaling Technology (CST). This collaboration will explore Leveragen’s proprietary Singularity Musculus platform to expedite the development of mouse-derived nanobodies tailored for reagent antibody applications.
Devyser signed a collaboration agreement with Viska AI. This marks a significant milestone in our journey towards innovation and excellence, leveraging AI to enhance clinical decision-making—starting with transplantation and expanding into many more opportunities beyond.
Eberbach Corporation has teamed up with Bioz to integrate Bioz Badges into its product pages, allowing researchers to instantly access peer-reviewed citations that demonstrate real-world use of its hand motion, reciprocal, and orbital shakers.
The Ontario Brain Institute is partnering with Canadian startup EpiSign Inc to improve diagnosis and care for people with rare neurological genetic disorders.
Revvity announced an agreement with Genomics England to further collaborate on the Generation Study. Under the new contract, Revvity will now also provide DNA sequencing services to help screen newborns for rare genetic conditions.
Beckman Coulter Life Sciences signed two collaborations:
- With T-NeuroDx to assess a next-generation blood test for early detection of Alzheimer’s disease.
- With Rarity Bioscience they formed a co-exclusive distribution agreement to extend the capabilities of flow cytometry to clinical molecular research.
Oxford Nanopore Technologies inked a partnership with Dubai Health to promote next-generation sequencing for carrier screening in the region.
Mainz Biomed struck a deal to develop a blood-based test for the early detection of pancreatic cancer with Liquid Biosciences.
City University of Hong Kong (CityUHK) is partnering with Cellomics to design a circulating tumor cell (CTC) screening assay that they intend to commercialize within the next two years.
Cure51 has partnered with Greater Paris University Hospitals – AP-HP to identify biomarkers of exceptional survival in patients with metastatic pancreatic cancer.
ACT Genomics has signed an agreement to exclusively offer mProbe Inc. OncoOmicsDx clinical cancer proteomics test in certain Asian markets.
ABL Diagnostics S.A signed an exclusive distribution deal with Riken genesis to promote and commercialize its infectious disease tests in Japan.
Product updates
MESO SCALE DIAGNOSTICS, LLC. launches new mouse and rat Ultrasensitive panels and assays for their S-Plex technology.
Navinci introduced the Naveni® Plex, the first multiplex in situ proximity ligation assay (isPLA) with a fluorescent readout, allowing for the simultaneous detection of three separate targets or protein-protein interactions, with unmatched specificity and sensitivity.
Alamar Biosciences, Inc. launched the NULISAseq Mouse Panel 120, an innovative biomarker profiling solution that provides the most comprehensive coverage of protein targets for expression analysis in mouse models.
Alpenglow Biosciences unveiled LUMI, an innovative user interface designed to enhance light-sheet microscopy. LUMI simplifies 3D imaging workflows, making high-resolution microscopy more accessible than ever.
Paige announced the launch of the Paige GI Suite, an AI-assisted diagnostic application designed to assist pathologists in detecting the most common conditions located within the GI tract.
ONI is revolutionizing lipid nanoparticle (LNP) analysis with the launch of the ONI Application Kit™: LNP Profiler, the first and only verified solution within the SMLM and super-resolution space for particle analysis.
Pixelgen Technologies has launched the Proximity Network Assay, a novel tool for nanoscale spatial analysis of immune cell proteins at the single-cell level. Built on its DNA-based 3D proteomics platform, the assay powers the new Pixelgen Proxiome Kit, offering high-resolution insights into disease mechanisms, drug response, and biomarker discovery.
Cytek Biosciences expands cell analysis offerings with the affordable, user-friendly Cytek® Muse® Micro System, increasing accessibility for flow cytometry applications in emerging and established markets.
Creative Proteomics has launched its state-of-the-art N-terminal Edman Degradation service, offering researchers a precise and reliable solution for protein sequence analysis.
Sphere Bio launched the Cyto-Cellect® Human IgG Kappa and Viability Assay Kit, the first multiplexed assay developed specifically for the Company’s new Cyto-Mine® Chroma platform.
CD Genomics unveiled its NGS-BSP. This cutting-edge technology is designed to advance our comprehension of epigenetic modifications, offering significant potential for research advancements in various fields.
Nona Biosciences integrates cutting-edge AI technology to enhance its fully human antibody platform, accelerating antibody discovery across key therapeutic areas
Singleron Biotechnologies launched MobiuScope, a single-cell RNA sequencing kit that provides full-length transcript analysis using short-read sequencing.
Beckman Coulter Life Sciences launched the CytoFlex Mosaic Spectral Detection Module for flow cytometry. They also announced FDA clearance of DxC 500i Clinical Analyzer, an integrated Clinical Chemistry and Immunoassay System
Cofactor Genomics launched OncoPrism genomic classifiers for colorectal, breast, bladder, and kidney cancer.
Infinity Bio, Inc. announce the release of their MuSIGHT™ mouse autoantibody reactome service offering.
BrightSpec, Inc. launched BrightSpec-MRR, the world’s first commercial MRR instruments in 50 Years.
Thermo Fisher Scientific has launched the Applied Biosystems SeqStudio Flex Dx Genetic Analyzer.
bioLytical launches the 1-Minute INSTI® multiplex HIV-1/2 syphilis antibody test in Australia
Sysmex America, Inc. announced the expansion of its 3-part differential automated haematology analyser line with the XQ-320™ for reliable and accurate CBC testing.
GeneDx announced Multiscore, an advanced AI-powered decision support tool designed to revolutionize genetic analysis by improving diagnostic efficiency, streamlining workflows, and enhancing clinical insights.
Adaptive Biotechnologies Corp. announced that it has launched an upgraded version of its clonoSEQ assay for MRD detection in diffuse large B-cell lymphoma using circulating tumor DNA.
Zymo Research Corp launched the Quick-16S Full-Length Library Prep Kit. It offers a fast workflow for full-length 16S amplicon library preparation, enabling researchers to prepare libraries for 96 samples with as little as 30 minutes of hands-on time. The kit is optimized for PacBio SMRTbell and Kinnex library prep kits and is also compatible with Oxford Nanopore platforms.
GenScript has acquired a license to prime editing technology from the Broad Institute of MIT and Harvard.
LGC Clinical Diagnostics launched Seraseq 22q11 Male Twins and Seraseq Euploid Male Twins reference materials for noninvasive prenatal testing (NIPT).
Objective Biotechnology, in collaboration with University of Minnesota researchers, launched the Autoinjector, a robotic system designed to automate the microinjection process used in genetic modification protocols for tiny organisms.
Helix launched a new clinico-genomic virtual registry of autoimmune disease patients. The registry consists of more than 23k consented individuals diagnosed with conditions such as lupus, rheumatoid arthritis, psoriasis, multiple sclerosis, Hashimoto’s disease, and Crohn’s disease.
Researchers from Evan Eichler’s lab at the University of Washington have updated Denovo-db, a curated database of germline de novo variants—mutations found in children but not in their parents. Version 1.6.1 includes data from large-scale whole-exome and whole-genome studies, now featuring variants from the Simons Simplex Collection (SSC).
CareDx, Inc. donor-derived cell-free DNA (dd-cfDNA)-based AlloSure transplant health assay is now commercially available for pediatric heart transplant patients of all ages, as well as patients who have received a simultaneous pancreas-kidney transplant.
Wren Laboratories launched NETest 2.0 for neuroendocrine tumor diagnostics. NETest 2.0 uses an AI-enhanced, noninvasive 51-gene mRNA expression algorithm to help diagnose NETs from 1 mL of blood collected in a proprietary tube.
Asuragen, a Bio-Techne brand has teamed up with Oxford Nanopore Technologies to launch the AmplideX Nanopore Carrier Plus Kit for carrier screening research.
QuidelOrtho introduces the Results Manager™ System, an informatics solution designed to address the growing demands of modern laboratories.
Accreditations & Regulatory Updates
FDA authorizes Visby Medical at-home MDx test for Chlamydia, Gonorrhea, Trichomoniasis
Invivoscribe’s Acute Myeloid Leukemia assay nabs regulatory compliance in UK & Switzerland
Guardant Health’s Shield blood-based colorectal cancer screening test is now covered by VA Community Care Program
Diasorin has received CE-IVDR marking for Candida Auris PCR Assay
Bio-Rad Laboratories has received the EU QMS Certification under Europe’s IVDR, which will enable the CE marking of 40 infectious disease molecular quality controls.
Epredia receives U.S. FDA 510(K) clearance for the E1000 Dx™ digital pathology solution designed to improve laboratory workflow in cancer diagnostics
Lumea’s Digital Diagnostic Suite™ (Viewer+™) Receives FDA 510(k) Clearance for Clinical Diagnosis.
FDA clears QIAGEN’s QiaStat-Dx mini gastrointestinal panel
Devyser Genomic Laboratories receives accreditation from College of American Pathologists. Devyser’s RHD test has received Class 4 IVD approval from the Therapeutic Goods Administration in Australia.
If you’re a biotech startup looking for life science or biotech talent, or you’d like to learn more about our recruitment services, submit your vacancy and a recruitment consultant that specialises in your field will be in touch shortly.
Alternatively, are you seeking advice on your next move? I’m here to help. Register with us today to schedule a confidential discussion about your career prospects.
